One BioMed is a molecular life science company that focuses on advancing human health through innovative technologies. Their flagship product, the Xceler8™ Solution, is an integrated platform designed for automated nucleic acid extraction and purification from various biological samples. This system includes the X8 OneTouch Instrument, ready-to-use cartridge kits, and proprietary software, enabling users to efficiently process samples with minimal hands-on time. The Xceler8 Solution is engineered to streamline workflows, allowing for random-access sample processing and the simultaneous execution of different extraction protocols, which enhances productivity and user experience.

The core of One BioMed's technology lies in the Xceler8 Technology, which employs a novel four-step chemistry-based approach to nucleic acid extraction. This method utilizes a patented reversible cross-linking technique to selectively capture and release nucleic acids, significantly reducing the time and labor associated with traditional extraction methods. The Xceler8 Platform is designed to handle a wide range of applications, from genomic and cellular RNA extraction to high molecular weight DNA extraction, making it a versatile tool for both research and clinical settings. By simplifying the extraction process and minimizing contamination risks, One BioMed aims to empower biomedical researchers with unprecedented access to high-quality nucleic acids for their studies.

Singapore

We are a molecular life science company dedicated to advancing human health through innovation. By designing and building breakthrough molecular platforms that are both accessible and best-in-class, One BioMed is providing biomedical researchers and clinicians with unprecedented access to cutting-edge tools. 

One BioMed

Company Details